Semaglutide is effective in achieving weight loss in liver transplant recipients

Liver Transpl. 2024 Feb 1;30(2):223-225. doi: 10.1097/LVT.0000000000000247. Epub 2023 Aug 29.

Authors

Kenneth W Chow¹, Brittney Ibrahim^{2

3}, Kabir Rahal², Ryan H Hsu⁴, Teresa Tan², Katherine Meneses², Sammy Saab^{2

3}

Affiliations

¹ Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
² Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
³ Department of Surgery, University of California at Los Angeles, Los Angeles, California, USA.
⁴ Department of Bioengineering, Jacobs School of Engineering, University of California, San Diego, La Jolla, California, USA.

PMID: 37639288
DOI: 10.1097/LVT.0000000000000247

No abstract available

MeSH terms

Diabetes Mellitus, Type 2*
Glucagon-Like Peptides / therapeutic use
Humans
Hypoglycemic Agents
Liver Transplantation* / adverse effects
Weight Loss

Substances

semaglutide
Glucagon-Like Peptides
Hypoglycemic Agents